Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
GH Research PLC
1KACurrent price
8.35 EUR
0 EUR (0.00%)
Last closed
9.24 USD
Company
www.ghres.com
ISIN
IE000GID8VI0
Sector
Healthcare
Industry
Biotechnology
Exchange
Frankfurt Exchange
Capitalization
447 961 920 USD
Yield for 12 month
+13.98 %
1Y
3Y
5Y
10Y
15Y
1KA
GH Research PLC, together with its subsidiary GH Research Ireland Limited, engages in developing various therapies to treat psychiatric and neurological disorders. It is involved in the development of 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD). The company's lead program is GH001, an inhalable mebufotenin product candidate, currently under Phase 2b clinical trial for the treatment of patients with TRD, as well as Phase 2a clinical trials for the treatment of Bipolar II disorder and postpartum depression. It is also involved in the development of GH002, an intravenous mebufotenin product candidate for IV administration, currently under Phase 1 clinical trials for the treatment of psychiatric or neurological disorder; and GH003, an intranasal mebufotenin product candidate for nasal administration, which is currently in preclinical development with a focus on psychiatric and neurological disorders. The company was founded in 2018 and is based in Dublin, Ireland. Address: Joshua Dawson House, Dublin, Ireland, D02 RY95
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
32 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
+80 000 USD
Current Year
-315 000 USD
Last Year
-47 000 USD
Current Quarter
-78 000 USD
Last Quarter
–
Key Figures 1KA
1 year
3 years
5 years
10 years
EBITDA
-45 526 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-12.74 %
PEG Ratio
–
Return On Equity TTM
-16.2 %
Wall Street Target Price
32 USD
Revenue TTM
–
Book Value
3.82 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-0.67 USD
Diluted Eps TTM
-0.67 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics 1KA
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 1KA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation 1KA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
-11.9745
Price Book MRQ
2.2547
Financials 1KA
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators 1KA
For 52 weeks
5.05 USD
14.99 USD
50 Day MA
7.76 USD
Shares Short Prior Month
1 601 025
200 Day MA
10.09 USD
Short Ratio
29.92
Shares Short
1 779 944
Short Percent
12.03 %
BeatStart